[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336104-105":59,"doc-detail-336104-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","potential-value-of-hsp90a-in-prognosis-of-triple-negative-breast-cancer","Potential Value of HSP90a in Prognosis of Triple-Negative Breast Cancer","","Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive subtype lacking ER, PR, and HER2 expression, making endocrine therapy ineffective and standard treatment selection difficult. A retrospective study evaluated the prognostic potential of HSP90a in 127 TNBC patients and 127 healthy controls. Venous blood biomarkers including HSP90a, CEA, CA199, and CA125 were measured alongside clinical characteristics. Multivariate analysis linked HSP90a level with PFS and OS, supporting its relevance to adverse disease features.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-value-of-hsp90a-in-prognosis-of-triple-negative-breast-cancer/336104/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-value-of-hsp90a-in-prognosis-of-triple-negative-breast-cancer/336104.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is prognosis determination challenging in triple-negative breast cancer (TNBC)?","Question",{"text":112,"@type":113},"TNBC lacks estrogen receptors (ER), progesterone receptors (PR), and HER2, and is insensitive to endocrine therapy, which limits standard treatment options.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HSP90a evaluated in the study?",{"text":117,"@type":113},"Venous blood was collected from 127 TNBC patients and 127 healthy controls, and HSP90a levels were measured alongside CEA, CA199, and CA125, with clinical variables recorded.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were independently associated with progression-free survival (PFS) and overall survival (OS)?",{"text":121,"@type":113},"Distant metastasis, TNM stage, and HSP90a level were independent factors for PFS; BMI, tumor size, TNM stage, surgical history, and HSP90a level were independent factors for OS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336104,1790193101,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","CLINICAL RESEARCH  \ne-ISSN 1643-3750  \n© Med Sci Monit, 2024; 30: e943049 DOI: 10. 12659/MSM.943049  \nReceived: 2023.11.01  \nAccepted: 2024.02.08  \nAvailable online: 2024.02.21  \nPublished: 2024.03.30  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nCDEF 1,2 G 1,2  \nE 3  \nA 1,2  \nCorresponding Author: Financial support:  \nConflict of interest:  \nPotential Value of HSP90a in Prognosis of Triple-Negative Breast Cancer  \nHan Fei Wang Ying Chen Bang Cao Jing Pei  \n1 Department of Breast Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China  \n2 Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, PR China  \n3 Department of Breast Surgery, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui, PR China  \nJing Pei, e-mail: [peijing@ahmu.edu.cn](peijing@ahmu.edu.cn)  \nThis study was supported by the First Affiliated Hospital of Anhui Medical University Clinical Research Project (grant number LCYJ2021YB008), Anhui Provincial Health Soft Science Project (2020WR02004), and the Anhui Medical University Research Fund (2023xkj129)  \nNone declared  \nBackground: Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer, accounting for 12-18% of all breast cancer cases. It exhibits high heterogeneity and aggressiveness, resulting in a poorer prognosis with a high risk of early recurrence and metastasis. Due to the lack of expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), as well as insensitivity to endocrine therapy, determining a standard treatment for TNBC is challenging. The identification of potential prognostic biomarkers is crucial for developing personalized treatment strategies for patients.  \nMaterial/Methods: Our study investigated the potential value of HSP90a in TNBC prognosis. A retrospective analysis was conducted on 127 TNBC patients and 127 Healthy controls from March 1, 2019 to July 31, 2022. Venous blood was collected and tested for HSP90a, CEA, CA199, and CA125, and we recorded the clinical characteristics of the patients, including age, BMI, alcohol consumption status, surgical history, CEA level, CA199 level, CA125 level, HSP90a level, tumor size, distant metastases, lymph node metastasis, and TNM stage. Univariate and multivariate methods were used to screen independent risk factors for progression-free survival (PFS) and overall survival (OS).  \nResults: HSP90a is not only upregulated in TNBC but is also highly correlated with lymph node metastasis and TNM stage. The results of multivariate analysis showed that distant metastasis, TNM stage and HSP90a level were independent factors associated with PFS. BMI, tumor size, TNM stage, surgical history, and HSP90a level were independent factors influencing OS.  \nConclusions: Our research findings demonstrate a significant association between high HSP90a expression and adverse clinical features, suggesting a poorer prognosis for TNBC patients.  \nKeywords: Prognosis • HSP90AA1 Protein, Human • Triple Negative Breast Neoplasms  \nFull-text PDF: [https://www.medscimonit.com/abstract/index/idArt/943049](https://www.medscimonit.com/abstract/index/idArt/943049)  \n2880  4  4  43  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Common AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne943049-1  \nIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System][ISI Journals Master List] [","cbCaip9bUerIpiHj","https://ap.wps.com/l/cbCaip9bUerIpiHj","pdf",559284,"English","# Introduction\n# Material/Methods\n# Results\n# Conclusions","[{\"question\":\"Why is prognosis determination challenging in triple-negative breast cancer (TNBC)?\",\"answer\":\"TNBC lacks estrogen receptors (ER), progesterone receptors (PR), and HER2, and is insensitive to endocrine therapy, which limits standard treatment options.\"},{\"question\":\"How was HSP90a evaluated in the study?\",\"answer\":\"Venous blood was collected from 127 TNBC patients and 127 healthy controls, and HSP90a levels were measured alongside CEA, CA199, and CA125, with clinical variables recorded.\"},{\"question\":\"Which factors were independently associated with progression-free survival (PFS) and overall survival (OS)?\",\"answer\":\"Distant metastasis, TNM stage, and HSP90a level were independent factors for PFS; BMI, tumor size, TNM stage, surgical history, and HSP90a level were independent factors for OS.\"}]","Potential Value of HSP90a in Prognosis of Triple-Negative Breast Cancer | PDF",1790013610,25]